April 2011
Volume 52, Issue 14
ARVO Annual Meeting Abstract  |   April 2011
Collagen Crosslinking For The Treatment Of Keratoconus
Author Affiliations & Notes
  • Markus Groppe
    John Radcliffe Hospital, Oxford, The Nuffield Laboratory of Ophthalmology, Oxford, United Kingdom
    Department of Ophthalmology, Royal Berkshire Hospital, Reading, United Kingdom
  • Martin Leyland
    Department of Ophthalmology, Royal Berkshire Hospital, Reading, United Kingdom
  • Footnotes
    Commercial Relationships  Markus Groppe, None; Martin Leyland, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 5205. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Markus Groppe, Martin Leyland; Collagen Crosslinking For The Treatment Of Keratoconus. Invest. Ophthalmol. Vis. Sci. 2011;52(14):5205.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : The aim of the study was to examine the ability of riboflavin/UVA-induced collagen crosslinking to reduce the progression of keratoconus.

Methods: : A retrospectuive review of fourteen eyes of 13 patients with moderate or advanced progressive keratoconus was performed. After central corneal abrasion, photosensitizing riboflavin drops were applied and the eyes exposed to UVA for 60 minutes. Postoperative examinations were performed, including visual acuity testing, corneal topography, slit-lamp examination. The follow-up time was between 3 months and 2 years.

Results: : In all treated eyes the progression of keratoconus was stopped and in 79% of treated eyes a average reduction of the maximal keratometry readings by 0.79 diopters was noted. Corneal and lens transparency remained unchanged. Visual acuity was not affected by the treatment.

Conclusions: : Collagen crosslinking is a way for stopping the progression of keratectasia in patients with keratoconus. It seems to be a safe and promising procedure to stabilise the refraction and the corneal topography, and thus to stop the progression of visual loss.

Keywords: cornea: clinical science • keratoconus • topography 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.